Ptc Therapeutics (PTCT) Change in Acquisitions & Divestments (2013 - 2026)

Ptc Therapeutics' Change in Acquisitions & Divestments history runs 14 years deep, the most recent figure standing at $376.4 million for Q1 2026.

• On a quarterly basis, Change in Acquisitions & Divestments rose 4130.65% year-over-year to $376.4 million in Q1 2026; TTM through Mar 2026 was $42.0 million, a 92.46% decrease from a year earlier, with the FY2025 full-year figure at $58.8 million, down 89.3% from the prior year.
• Change in Acquisitions & Divestments climbed to $376.4 million in Q1 2026 per PTCT's latest filing, from -$365.5 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $508.0 million in Q4 2024 and bottomed at -$365.5 million in Q4 2025.
• The 5-year median for Change in Acquisitions & Divestments is $10.7 million (2023), against an average of $64.3 million.
• Across the five-year window, Change in Acquisitions & Divestments jumped 14300.0% in 2022 and slumped 171.96% in 2025, its largest moves.
• Year by year, Change in Acquisitions & Divestments stood at $300.8 million in 2022, then plunged by 97.4% to $7.8 million in 2023, then surged by 6387.68% to $508.0 million in 2024, then plunged by 171.96% to -$365.5 million in 2025, then soared by 202.96% to $376.4 million in 2026.
• Per Business Quant, the three latest PTCT Change in Acquisitions & Divestments figures stand at $376.4 million (Q1 2026), -$365.5 million (Q4 2025), and $23.0 million (Q3 2025).